share_log

UnitedHealth | 8-K: Signing of Underwriting and Pricing Agreements

SEC announcement ·  Mar 21 16:37
Summary by Moomoo AI
On March 19, 2024, UnitedHealth Group Incorporated, a healthcare and insurance giant, entered into agreements to sell a series of notes with varying interest rates and maturities, totaling $5.5 billion. The notes, ranging from 4.600% to 5.500% in interest rates and with maturity dates spanning from 2027 to 2064, were sold under an Underwriting Agreement and a Pricing Agreement with major financial institutions including BofA Securities, Barclays Capital, J.P. Morgan Securities, and Mizuho Securities USA. The sale was completed on March 21, 2024, with the issuance of the notes under an existing Indenture with U.S. Bank Trust Company as trustee. The transaction was registered under the Securities Act of 1933 and incorporated into UnitedHealth's automatic shelf registration statement. The company filed the necessary documents with the SEC, including the Underwriting and Pricing Agreements, Officers' Certificates, Company Orders, and legal opinion regarding the validity of the notes.
On March 19, 2024, UnitedHealth Group Incorporated, a healthcare and insurance giant, entered into agreements to sell a series of notes with varying interest rates and maturities, totaling $5.5 billion. The notes, ranging from 4.600% to 5.500% in interest rates and with maturity dates spanning from 2027 to 2064, were sold under an Underwriting Agreement and a Pricing Agreement with major financial institutions including BofA Securities, Barclays Capital, J.P. Morgan Securities, and Mizuho Securities USA. The sale was completed on March 21, 2024, with the issuance of the notes under an existing Indenture with U.S. Bank Trust Company as trustee. The transaction was registered under the Securities Act of 1933 and incorporated into UnitedHealth's automatic shelf registration statement. The company filed the necessary documents with the SEC, including the Underwriting and Pricing Agreements, Officers' Certificates, Company Orders, and legal opinion regarding the validity of the notes.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more